Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years With Atopic Dermatitis

NCT06998056 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis (Eczema)

Interventions

DRUG: ARQ-151 cream 0.05%

Sponsor

Arcutis Biotherapeutics, Inc.